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SUMMARY – In the last four decades, the incidence of pancreatic cancer has tripled in Western 
countries. More than 90% of all pancreatic cancers are detected in the advanced stage of the disease 
when surgical treatment is no longer possible and survival after initial diagnosis is usually very short. 
The aim of this study was to correlate magnetic resonance imaging (MRI) established diagnosis of 
chronic pancreatitis, benign lesion and malignant neoplasm with final histopathology. The study 
included 29 patients in whom the nature of pancreatic pathology could not be determined clinically 
and by other imaging modalities including abdominal ultrasonography, endoscopic retrograde cho-
langiopancreatography and multislice computed tomography. MRI examination was performed and 
radiological report was compared with histopathology assessment of the pancreatic lesion detected. 
The data obtained indicated systematic conformity between radiological and histopathology findin-
gs, confirmed high diagnostic accuracy of MRI for selected pancreatic pathology, and demonstrated 
the role of MRI as a problem solving diagnostic imaging modality in undetermined pancreatic 
changes. 
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Introduction
In the time of rapid development of diagnostic 
methods, pancreatic diseases and especially pancreatic 
cancer remain a major diagnostic challenge. Differen-
tiation of pancreatic changes by diagnostic imaging 
methods (multislice computed tomography, MSCT; 
magnetic resonance imaging, MRI with magnetic 
resonance cholangiopancreatography, MRCP; ul-
trasonography, US; endoscopic retrograde cholan-
giopancreatography, ERCP; and endoscopic US) is 
a demanding procedure and the answer is often not 
unambiguous. The most important objective in the as-
sessment of pancreatic disease is to determine whether 
the observed pathology represents a neoplasm, in-
flammatory change or occurrence of a neoplasm in 
chronic pancreatitis. Differential diagnosis of pan-
creatic masses is very broad and includes pancreatitis, 
adenocarcinoma, solid pseudopapillary tumor, neu-
roendocrine tumors, mucinous cystic tumors, serous 
cystadenoma and others1. If the lesion is diagnostically 
characterized as a neoplasm, it is necessary to distin-
guish whether it is benign or malignant. Malignant 
lesions are further classified according to the TNM 
staging system with special attention focused on the 
local spread to determine whether surgical treatment 
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is possible. Among the neoplasms of gastrointestinal 
tract, pancreatic cancer is the most common cause of 
death2 and mortality of patients is extremely high. The 
term “pancreatic cancer” in clinical practice implies ad-
enocarcinoma, which usually makes up to 95% of all 
primary malignant lesions of the pancreas3. One of 
the most common diagnoses in pancreatic pathology 
besides pancreatic cancer is chronic pancreatitis. It is 
characterized by progressive and irreversible impair-
ment of the pancreatic parenchyma, which results in 
permanent loss of exocrine and endocrine pancreatic 
function. Compared with general population, patients 
with chronic pancreatitis have a 2.3-18.5 times greater 
relative risk of pancreatic cancer4. More than 90% of 
all pancreatic carcinomas are detected in the advanced 
stage of the disease when surgical treatment is no lon-
ger possible and survival after initial diagnosis is usually 
very short. Therefore, the aim of diagnostic imaging is 
early detection of pancreatic cancer in order to expand 
therapeutic options from palliative to curable. MRI 
with MRCP is only comparable to endoscopic US in 
the quality of depiction of pancreatic ducts, biliary tree, 
pancreatic parenchyma and peripancreatic structures5. 
MRI and MRCP have a unique capability to provide 
assessment of all these structures in only one nonin-
vasive examination5, thereby allowing evaluation of 
the nature and extent of pancreatic disease. In the past 
few years, there have been many discussions regarding 
sensitivity and specificity of diagnostic procedures6-8 
used in diagnosing pancreatic pathology, particularly 
regarding diagnosing and spread assessment of pancre-
atic cancer. The aim of this study was to correlate MRI 
established diagnosis of chronic pancreatitis, benign le-
sion or malignant neoplasm with final histopathology 
in patients with clinically and radiologically undeter-
mined pancreatic changes.
Patients and Methods
At the University Department of Diagnostic and 
Interventional Radiology, Sestre milosrdnice Univer-
sity Hospital Center, we conducted a retrospective 
study in the period of 6 years. In 80 patients (47 men 
and 33 women) referred for radiological diagnostic 
evaluation of suspected pancreatic pathology, we ap-
plied the following diagnostic algorithm: abdominal 
US, ERCP and MSCT examination. The study ex-
cluded 51 patients in whom previously proposed di-
agnostic algorithm revealed the nature of the disease 
and those without the histopathology assessment of 
the observed pancreatic change. The study included 
29 patients (14 women and 15 men, 15 to 72 years of 
age), who participated in the suggested diagnostic al-
gorithm and after inability to radiologically determine 
the nature of the pancreatic change, MRI examina-
tion was performed on a 1T scanner (MR Harmony 
Siemens, Erlangen, Germany). MRI sequences with 
breath hold included axial T1WI in phase (TR 132 
ms; TE 3,65 ms), axial T1WI out of phase (TR 132 
ms; TE 7,97 ms), axial T1WI with fat suppression 
(T1WI with FAT SAT; TR 176 ms; TE 3,75 ms), 
axial T2 true Fast Imaging with Steady Precession 
(trueFISP; TR 4,56 ms; TE 1,85 ms), axial T2 Half 
Fourier Acquisition Single Shot Turbo Spin Echo 
(HASTE; TR 1100 ms; TE 120 ms), axial dynamic 
contrast-enhanced T1WI in phase and out of phase 
after 30, 60, 90, 120 s and 180-200 s (the equilib-
rium phase) and delayed T1WI with FAT SAT after 
application of contrast medium. MRCP examination 
included coronal T2 HASTE volume (slice thick-
ness 4 cm; TR 4500 ms; TE 755 ms) and coronal T2 
HASTE (slice thickness 4 mm; TR 1430 ms; TE 87 
ms). The intravenous contrast medium used was gado-
linium DTPA (Bayer Schering Pharma AG, Berlin, 
Germany), 0.2 mL/kg. Pathologic MRI findings were 
suspected when the signal of the pancreatic paren-
chyma was lower compared to the signal of the liver 
parenchyma. Focal pancreatic lesion was suspected 
when the signal of the lesion was lower than the sig-
nal of the surrounding parenchyma on T1WI. Other 
sequences enabled characterization of the pathologic 
changes detected. A statistically significant corre-
spondence between the diagnoses set by the radiolo-
gist and the pathologist was examined for the follow-
ing pancreatic disorders: chronic pancreatitis, benign 
pancreatic lesion and malignant pancreatic neoplasm. 
The data obtained were analyzed with the follow-
ing statistical tests: proportion of overall agreement, 
proportions of specific agreement, Fisher’s exact test, 
kappa coefficient, tetrachoric correlation and McNe-
mar’s test. P value of <0.05 was taken as the level of 
statistical significance. Postoperative histopathologic 
analysis of samples was conducted according to the 
standard procedures for the preparation and analysis 
of formalin-fixed and paraffin embedded specimens. 
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Results
The radiologist classified 12 patients as chronic 
pancreatitis and the histopathology assessment re-
vealed the presence of the disease in 14 cases. The pro-
portion of overall agreement between the pathologist 
and the radiologist was 86.2%. A benign lesion was 
reported in 8 patients by the radiologist and histopa-
thology confirmed the diagnosis in 5 patients. For a 
malignant neoplasm, the radiologist identified the le-
sion in 8 patients and histopathology proved the pres-
ence of the disease in 5 cases. The proportion of over-
all agreement for the diagnosis of benign lesion and 
malignant neoplasm between examiners was 89.7%. 
All proportions were statistically significant (Tables 
1 and 2). The proportions of specific agree ment for 
positive agreement (presence of the disease) and nega-
tive agreement (absence of the disease) was equally 
high for chronic pancreatitis (84.6%; 87.5%). For the 
Fig. 1. Axial T1W1 with FAT SAT. Depiction of pancre-
atic morphology and surrounding fat planes. Left adrenal 
adenoma (arrow).
Fig. 2. Axial T1WI out of phase. Chronic pancreatitis. Pa-
renchymal atrophy with dilatation and beading of the pan-
creatic duct.
Table 2. Proportion of overall agreement and proportions of 
specific agreement for the diagnoses of chronic pancreatitis, 
benign lesion and malignant neoplasm
Proportion of overall agreement
Po SE Po Fisher's exact test, P
Chronic pancreatitis 0.862 0.064 <0.001
Benign lesion 0.897 0.057 <0.001
Malignant neoplasm 0.897 0.057 <0.001
Proportions of specific agreement
Ps+ SE Ps+ Ps- SE Ps-
Chronic pancreatitis 0.846 0.067 0.875 0.061
Benign lesion 0.769 0.078 0.933 0.046
Malignant neoplasm 0.769 0.078 0.933 0.046
po = proportion of overall agreement
ps+ = proportion of specific agreement for positive answers
ps– = proportion of specific agreement for negative answers
SE = standard error
Chronic pancreatitis
Histopathology Total
  0   1
MRI 0 14   3 171   1 11 12
Total 15 14 29
Benign lesion
Histopathology  Total
  0 1
MRI 0 21 0 211   3 5   8
Total 24 5 29
Malignant neoplasm
Histopathology  Total
  0 1
MRI 0 21 0 211   3 5   8
Total 24 5 29
Table 1. Frequency tables for the diagnosis of chronic pan-
creatitis, benign lesion and malignant neoplasm
MRI = magnetic resonance imaging; 0 = absence of disease;
1 = presence of disease
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diagnoses of benign lesion and malignant neoplasm, 
the proportions of specific agreement between the pa-
thologist and the radiologist was very high for nega-
tive agreement (93.3%), but positive agreement was 
much lower (76.9%) (Table 2). Whether this differ-
ence was statistically significant we examined using 
the exact test based on the cumulative binomial dis-
tribution. There were no statistically significant dif-
ferences in marginal frequencies for both appraisers 
(Table 3). Kappa coefficients were statistically signifi-
cant and the values were as follows: chronic pancrea-
titis 0.722, benign lesion 0.707 and malignant neo-
plasm 0.707 (Table 4). Tetrachoric correlation showed 
very high level of agreement between evaluators for 
all three pathologic entities. All coefficients were sta-
tistically significant and close to 1, which represents 
maximal agreement (Table 5). The most important 
Table 3. Exact test based on cumulative binomial distribu-
tion for positive findings of chronic pancreatitis, benign le-





Table 4. Kappa coefficients for the diagnoses of chronic pan-
creatitis, benign lesion and malignant neoplasm
Kappa Standard error Kappa P
Chronic pancreatitis 0.722 0.128 <0.001
Benign lesion 0.707 0.153 <0.001
Malignant 
neoplasm 0.707 0.153 <0.001
Fig. 4. Axial T1WI. Expansive lesion in the head of the 
pancreas (arrow) with displacement of the superior mesen-
teric artery and vein.
Fig. 3. Axial T1WI out of phase. Enlargement of the pan-
creatic tail (arrow) with slightly lower signal intensity com-
pared to the surrounding pancreatic parenchyma.
Table 5. Tetrachoric correlation for the diagnoses of chronic 
pancreatitis, benign lesion and malignant neoplasm
rho Standard error rho  P
Chronic pancreatitis 0.921 0.077 <0.001
Benign lesion 0.897 0.113 <0.001
Malignant neoplasm 0.897 0.113 <0.001
rho = tetrachoric correlation
Fig. 5. Axial T1WI after IV contrast medium administra-
tion. Expansive lesion in the head of the pancreas (arrow). 
Lower signal intensity of the lesion compared to the sur-
rounding pancreatic parenchyma. Displacement of the supe-
rior mesenteric artery and vein.
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MRI imaging features of the pancreas and selected 
pancreatic pathology are represented in the following 
figures. Pancreatic parenchyma and clear depiction of 
surrounding fat planes is shown on T1WI with FAT 
SAT (Fig. 1). Imaging features of chronic pancreatitis 
are presented in Figure 2. Detection and character-
ization of a pancreatic lesion is based on the change in 
size and shape of the pancreas, as well as observation 
of post-contrast enhancement (Figs. 3, 4 and 5). In-
volvement of vascular structures in case of a malignant 
lesion is shown in Figure 6. The importance of T2WI 
in delineation of fluid containing lesion and pancre-
atic duct is presented in Figures 7 and 8. MRCP is 
shown in Figure 9.
Discussion
In the last four decades, the incidence of pancreatic 
cancer has tripled in Western countries and accounts 
for approximately 3% of cancers in both sexes. The in-
cidence rate for pancreatic cancer in Croatia in 2008 
was 15.5 per 100,000 men and women per year9. In 
Croatia, 374 new pancreatic carcinomas in men and 
316 new pancreatic carcinomas in women were diag-
nosed in 2008. The 75-79 age group was most com-
monly affected10. Risk factors for pancreatic cancer are 
still not clearly defined11.
Data obtained from this study indicate system-
atic conformity between evaluations made by the ra-
diologist using MRI and the histopathology report 
in characterization and differentiation of chronic 
pancreatitis, benign lesion and malignant neoplasm. 
Fig. 6. Axial T1WI with FAT SAT after IV contrast me-
dium administration. Thrombus in the superior mesenteric 
artery (white arrow). Expansive lesion in the body and tail 
of the pancreas (black arrow).
Fig. 7. Axial T2 HASTE. Cystic lesion in the head of the 
pancreas (arrow).
Fig. 9. MRCP. Dilatation of the common bile duct (arrow) 
with stenosis at the level of the ampulla of Vater (curved ar-
row). Dilatation of the pancreatic duct (arrowhead).
Fig. 8. Axial T2 HASTE. Dilatation and beading of the 
pancreatic duct (arrow).
142 Acta Clin Croat,  Vol. 50,   No. 2,  2011
Ana Šverko et al. Pancreatic diseases – correlation between MRI and histopathology
The proportion of overall agreement between the ra-
diologist and the pathologist was 86.2% for chronic 
pancreatitis, 89.7% for benign lesion and 89.7% for 
malignant neoplasm. As the proportion of overall 
agreement does not distinguish agreement on posi-
tive (presence of the disease) and negative (absence 
of the disease) answers, we applied the proportions 
of specific agreement. Positive agreement and nega-
tive agreement was equally high for chronic pancrea-
titis (84.6%; 87.5%), indicating a satisfactory level of 
agreement for positive and negative findings. For the 
diagnosis of benign lesion and malignant neoplasm, 
the situation was different. Considering that benign 
and malignant lesions are a less common pancreatic 
pathology, negative agreement between the radiolo-
gist and the pathologist was very high (93.3%), but 
positive agreement was lower (76.9%), suggesting that 
the radiologist in the interpretation of MRI tends to 
overlook these lesions, probably because of their lower 
occurrence in general population. Whether this dif-
ference was statistically significant we examined us-
ing McNemar’s test. The assumption for the use of 
McNemar’s test is that the sum of frequencies in cases 
where appraisers do not agree should be greater than 
or equal to 10. Since this assumption was not met in 
our case, we used the exact test based on a cumulative 
binomial distribution. There were no statistically sig-
nificant differences in marginal frequencies for both 
appraisers, indicating that there is no greater or lesser 
tendency of the radiologist to give a positive or nega-
tive answer in relation to the findings of the patholo-
gist. We concluded that the formerly mentioned dif-
ference observed with the evaluation of benign lesions 
and malignant neoplasms could be declared random. 
An additional measure that describes the congruence 
between assessments was obtained using kappa statis-
tics. The agreement of the evaluators was slightly high-
er for the diagnosis of chronic pancreatitis than for the 
diagnoses of benign lesion and malignant neoplasm. 
Since all kappa coefficients were statistically signifi-
cant, the agreement between the radiologist and the 
pathologist was greater than it would be expected ran-
domly. As a better measure of the agreement between 
evaluators for categorical data than kappa coefficients, 
we used tetrachoric correlation. It was shown that the 
agreement between the observers was very high and 
statistically significant for all three pathologic enti-
ties (all coefficients were close to 1, which represents 
maximal agreement). Based on the statistical analysis 
of the data provided, we concluded that MRI has a 
high degree of diagnostic accuracy for selected pan-
creatic pathology. Abdominal US is often used as 
the first imaging modality in patients with suspected 
pancreatic pathology. Disadvantages of abdominal US 
include dependence on the experience of the observer 
and frequent inability to perform appropriate exami-
nation due to air in gastrointestinal tract5. MSCT is 
widely available, highly diagnostically accurate12 and 
hence is commonly the initial imaging method used 
in patients with suspected pancreatic cancer. Howev-
er, small solid masses as well as development of carci-
noma in chronic pancreatitis remain a major diagnos-
tic problem13. Drawbacks of MSCT also include the 
application of ionizing radiation and the possibility of 
complications due to intravenous administration of 
iodine contrast medium. ERCP is very sensitive in de-
tecting bile and pancreatic duct disorders but it is not 
always highly specific and it is associated with a 5%-
10 % risk of significant complications14. MRI differ-
entiation of a malignant lesion in chronic pancreatitis 
can also be very difficult. Gross morphology of the 
pancreas and clear depiction of fat planes surround-
ing the pancreas is best shown on T1WI with FAT 
SAT, which also provides good contrast between pan-
creatic parenchyma and focal pancreatic masses. The 
imaging features of chronic pancreatitis include low-
signal-intensity pancreas on T1WI with FAT SAT, 
decreased and delayed enhancement after IV contrast 
administration, parenchymal atrophy or enlargement, 
formation of pseudocysts, dilatation and beading of 
the pancreatic duct often with intraductal calcifica-
tions15. A smoothly dilated pancreatic duct with an 
abrupt interruption, dilatation of both biliary and 
pancreatic duct (“double-duct sign”) and obliteration 
of the perivascular fat planes favor the diagnosis of 
cancer. Detection and characterization of a pancreatic 
neoplasm and assessment of the spread of a malignant 
lesion is based on the change in size and shape of the 
pancreas as well as on the observation of post-contrast 
enhancement. To reveal the nature of the solid pan-
creatic lesion noticed, we performed a dynamic con-
trast-enhanced study. Early arterial phase is of excep-
tional importance for the depiction of hypervascular 
lesions (such as insulinomas). Malignant pancreatic 
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lesions can be detected during arterial (20-40 s after 
contrast medium administration) and venous (60-80 s 
after contrast medium administration) phase as areas 
of lower signal intensity on T1WI compared to the 
surrounding pancreatic parenchyma. On postcontrast 
images we can also assess the local and distant spread 
of the malignant disease, as well as the possible in-
volvement of vascular structures. On T2WI, fluid has 
a high signal intensity, therefore fluid containing le-
sions inside and outside of the pancreas, neoplasms 
with liquid content, cystic lesions, pancreatic and bil-
iary ducts can be depicted. MRCP is based on a heav-
ily T2WI with a possibility to utilize cross-section 
thickness from 20 to 100 mm. All signals except from 
structures filled with static or slowly moving liquid 
are diminished and a selective display of pancreatic, 
extrahepatic and intrahepatic ducts with great accu-
racy and minimal artifacts is obtained. ERCP could 
be diagnostically replaced with MRCP but MRCP 
does not provide the opportunity to perform interven-
tional procedures16,17. Drawbacks of MRI also include 
the inability to acquire samples for cytology analysis, 
decreased sensitivity for the detection of focal lesions 
in chronic pancreatitis and therefore reduced ability to 
detect malignant lesions.
This retrospective study demonstrated the role of 
MRI as a problem solving diagnostic imaging meth-
od in radiologically and clinically unclear pancreatic 
changes detected by other imaging modalities. Our 
results suggest that the improved tissue contrast of 
MRI and the ability to evaluate primary lesion and its 
effect on the adjacent structures make MRI advanta-
geous over other imaging methods in characterization 
of undetermined pancreatic changes. 
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Sažetak
KORELACIJA IZMEĐU SLIKOVNOG PRIKAZA MAGNETSKOM REZONANCIJOM
I HISTOPATOLOGIJE U DIFERENCIJACIJI BOLESTI GUŠTERAČE
A. Šverko, A. Tripalo-Batoš, M. Marotti, M. Mustapić, M. Bekavac Bešlin i B. Krušlin
U posljednja četiri desetljeća incidencija karcinoma gušterače se u zapadnim zemljama utrostručila. Više od 90% svih 
karcinoma gušterače otkriva se u uznapredovalom stadiju kada kirurško liječenje više nije moguće, a preživljavanje bole-
snika nakon postavljene dijagnoze je najčešće vrlo kratko. Cilj istraživanja bio je usporediti nalaz magnetske rezonancije s 
histopatološkim nalazom promjena u gušterači u bolesnika oboljelih od kroničnog pankreatitisa te dobroćudnih i zloćud-
nih novotvorina gušterače. U istraživanje je uključeno 29 bolesnika kod kojih se narav patološke promjene gušterače nije 
mogla utvrditi klinički niti drugim radiološkim metodama koje su uključivale ultrazvučni pregled, endoskopsku retro-
gradnu kolangiopankreatografiju te višeslojnu kompjutoriziranu tomografiju. Podaci istraživanja upućuju na podudaranje 
u radiološkoj i histopatološkoj prosudbi opaženih promjena, potvrđuju visoku točnost magnetske rezonancije u dijagnostici 
patoloških promjena gušterače i ilustriraju njenu važnost u procjeni naravi nejasnih promjena gušterače. 
Ključne riječi: Magnetska rezonancija, slikovni prikaz; Tomografija, spiralna kompjutorizirana; Ultrazvuk; Kolangiopan-
kreatografija, endoskopska retrogradna; Pankreatitis, kronični; Karcinom gušterače, duktalni
